000			01837nam a22003018a 4500
001			1920
003			CUTN
005			20160316122621.0
008			000804s2000 nyu b 001 0 eng
010			_a00062399
020			_a0198503849 (hbk)
020			_a0198503830
040			_aDLC _cDLC _dOrLoB-B
042			_apcc
050	0	0	_aRS403 _b.C23 2000
082			_a615.19
090			_aRS403 _bCab
100	1		_aCabri, Walter. _zCAB
245	1	0	_aFrom Bench to Market : _bthe Evolution of Chemical Synthesis / _cby Walter Cabri and Romano DiFabio.
260			_aNew York ; _aSingapore : _bOxford University Press, _c2000.
300			_a266 p. : _bill. _c25 cm.
504			_aIncludes bibliographical references and index.
520	1		_a"The authors use the real chemical history of the development of drugs from several therapeutic areas as detailed case studies, each chosen to illustrate a range of issues and methodologies in industrial chemistry. Several chapters cover the development of the various [Beta]-lactam antibiotics; two chapters describe the discovery and synthesis of the anticancer drugs Idarubicin and Paclitaxal; in another chapter, the synthesis of the anti-viral drug Acyclovir and the 'patent war' that resulted are explored." "Between them, the authors represent considerable first-hand experience in pharmaceutical research and development. The technical, practical, and strategic information they have amassed make this essential reading for graduate and undergraduate chemists intending to work in the pharmaceutical industry, as well as for industrial chemists themselves. Lecturers teaching courses in medicinal and organic chemistry will also find it useful."--BOOK JACKET.
650		0	_aPharmaceutical chemistry.
650		0	_aDrug development.
700	1		_aDiFabio, Romano.
942			_2ddc _cBOOKS
999			_c5272 _d5272